CVS Health Corporation Announces Early Results of Maximum Tender Offer and Election of Early Settlement
WOONSOCKET, R.I., Dec. 16, 2024 /PRNewswire/ -- CVS Health Corporation ("CVS Health" or the "Company,"NYSE: CVS) announced today the early...
Month: December 2024
Cemtrex’s Vicon Industries Secures $10.4 Million Valerus Expansion Order from State Government Corrections Customer
Hauppauge, NY, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services...
Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus’ First Gene Edited Weed Management Solution for U.S. Rice Growers
Cibus’ Rice Herbicide Tolerance (HT-3) Commercialization Efforts Continue Promising Progress to deliver a new Weed Management Solution for Farmers in...
Bridgewater Bancshares, Inc. Completes Acquisition of First Minnetonka City Bank
ST. LOUIS PARK, Minn.--(BUSINESS WIRE)--Bridgewater Bancshares, Inc. (Nasdaq: BWB) (“Bridgewater”), the parent company of Bridgewater Bank, announced the completion of...
Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates
BHV-1300 achieved deep lowering of targeted IgG, with reductions > 60% in the lowest subcutaneous dose tested in the MAD....
Beats on Base Releases Progress Update of its Revolutionary Meme Music Project and New AI Agents
Noosa Heads, QLD, Australia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Beats on Base, an AI project built on Coinbase’s Base...
Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)
Real-World Evidence Study Strengthens the Body of Evidence Supporting ANX005 for Treatment of GBS ANX005 Phase 3 Population Was Matched...
24/7 Market News Snapshot 16 December, 2024 – CEMTREX INC. (NASDAQ:CETX)
DENVER, Colo., 16 December, 2024 (247marketnews.com) – (NASDAQ:CETX) are discussed in this article. Cemtrex Inc. (CETX) is experiencing significant momentum...
$25.8 Million Royal Bank of Canada Project Finance Facility Secured by SolarBank
Funding will be used to develop and construct two battery energy storage projects acquired as part of the Solar Flow-Through...
The Shyft Group to Merge with Aebi Schmidt Group to Create A Specialty Vehicles Leader
Significant Scale in Attractive North American Market with Strong European Presence Highly Complementary Portfolios Create Opportunities to Better Serve Customers...
Viridian Therapeutics Reports Positive Topline Veligrotug Phase 3 THRIVE-2 Clinical Trial Results
DENVER, Colo., Dec 16, 2024 (247marketnews.com)- Viridian Therapeutics (NASDAQ: VRDN) reported positive topline data from the THRIVE-2 phase 3 clinical...
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)
Company plans to meet with FDA regarding potential sNDA submission in 1H 2025Call planned today at 8:30 a.m. (ET) to...
Military Metals Appoints Avrom Howard as VP Exploration
Vancouver, British Columbia--(Newsfile Corp. - December 16, 2024) - Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (the "Company"...
Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced...
KBR Expanding Capabilities for DoD Joint Mission Environment Test Capability Program with $445M Contract Win
HOUSTON, Dec. 16, 2024 /PRNewswire/ -- KBR (NYSE: KBR) announced it has been awarded an estimated $445 million cost-plus-fixed-fee contract...
Nexus Uranium Announces Expanded Winter Drill Program at Cree East
Vancouver, British Columbia--(Newsfile Corp. - December 16, 2024) - Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) (the "Company"...
Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships
BOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged...
Kraig Biocraft Laboratories Recaps Year of Breakthrough Achievements with BAM-1 Hybrids
World's First Commercially Viable Silkworms for Recombinant Spider Silk Production DENVER, Colo., Dec 16, 2024 (247marketnews.com)- Kraig Biocraft Laboratories, Inc....
First Hydrogen(TM) Explores Small Modular Reactors (SMRs) for Green Hydrogen Production
Vancouver, British Columbia--(Newsfile Corp. - December 16, 2024) - First Hydrogen Corp. (TSXV: FHYD) (OTC Pink: FHYDF) (FSE: FIT) ("FIRST...
Nokia and EOLO deploy Europe’s first 5G standalone mmWave network in Italy
Press Release Nokia and EOLO deploy Europe’s first 5G standalone mmWave network in Italy Nokia to deploy the first...
Immunovia to host a webcast with the opportunity to learn more about the positive clinical validation of its next-generation pancreatic cancer test
LUND, Sweden, Dec. 16, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, published positive results in...
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, December 16, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a...
Roadzen Inc. Announces Pricing of Public Offering
NEW YORK, Dec. 15, 2024 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN), (“Roadzen” or the “Company”), a global leader in...
Kelyniam Global, Inc., (“KLYG”) Announces Private Investment to Public Entity (“PIPE”) Closure of Securities Offering
Proceeds to Further Growth Objectives in 2025 CANTON, Conn., Dec. 16, 2024 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker...
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction
SOMERSET, N.J. & COPENHAGEN, Denmark--(BUSINESS WIRE)--Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better...
Global Uranium Corp. Announces Marketing Program
CALGARY, Alberta, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | OTCQB: GURFF | FRA: Q3J) (the...
PROSPECT RIDGE RESOURCES ADJOURNS ANNUAL GENERAL MEETING
VANCOUVER, BC, Dec. 13, 2024 /PRNewswire/ - Prospect Ridge Resources Corp. (the "Company" or "Prospect Ridge") (CSE: PRR) (OTC: PRRSF)...
Viridian Therapeutics to Webcast Veligrotug Phase 3 THRIVE-2 Topline Results on December 16, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious...
PennyMac Mortgage Investment Trust Declares Fourth Quarter 2024 Dividend for Its Common Shares
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--PennyMac Mortgage Investment Trust (NYSE: PMT) announced today that its Board of Trustees declared a cash dividend...
Douglas Emmett Declares Quarterly Cash Dividend
SANTA MONICA, Calif.--(BUSINESS WIRE)--Douglas Emmett, Inc. (NYSE: DEI), a real estate investment trust (REIT), announced today that its Board of...
Scope Technologies Corp. Responds to OTC Markets Request on Recent Promotional Activity
Vancouver, British Columbia--(Newsfile Corp. - December 13, 2024) - Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("Scope Technologies"...
OFS Credit Company Provides November 2024 Net Asset Value Update
CHICAGO--(BUSINESS WIRE)--OFS Credit Company, Inc. (Nasdaq: OCCI) (“OFS Credit”, the “Company”, “we”, “us” or “our”), an investment company that primarily...
Neurocrine Biosciences Announces FDA Approval of CRENESSITY™ (crinecerfont), a First-in-Class Treatment for Children and Adults With Classic Congenital Adrenal Hyperplasia
CRENESSITY, the first new treatment available in 70 years to the classic congenital adrenal hyperplasia (CAH) community, offers a paradigm-shifting...
Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of...
Legend Power Systems Schedules Fiscal 2024 Financial Results Release and Webinar
Vancouver, British Columbia--(Newsfile Corp. - December 13, 2024) - Legend Power Systems Inc. (TSXV: LPS) (OTCQB: LPSIF) ("Legend Power" or...
Ladder Capital Corp Announces Fourth Quarter 2024 Dividend to Holders of Class A Common Stock
NEW YORK--(BUSINESS WIRE)--Ladder Capital Corp (“Ladder” or the “Company”) (NYSE: LADR) today announced the declaration by its board of directors...
Global Uranium Corp. Announces Flow-Through Private Placement for up to C$1,500,000
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec....
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)
WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food...
Talen Energy Corporation Announces Closing of Incremental Term Loan B Financing and Related Repurchase of Common Stock
HOUSTON, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Talen Energy Corporation (“Talen” or the “Company”) (NASDAQ: TLN) announced today that the...
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options...